HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Andrew Jergens launching new advertising campaign for the antiperspirant and deodorant brand following completion of its purchase from Chattem Sept. 15. Jergens announced it would acquire the brand in a $160 mil. deal (1"The Rose Sheet" Aug. 28, p. 11). The firm hopes to expand Ban's image beyond its venerable roll-on formula

You may also be interested in...

Andrew Jergens $160 Mil. Ban Acquisition Extends Skin Care Stable

Andrew Jergens will acquire the Ban antiperspirant and deodorant business from Chattem, marking the company's first expansion beyond the moisturizing, cleansing and facial care categories, the firm said Aug. 24.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts